Vanguard National Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135 Sell
10
-29
-74% -$347 ﹤0.01% 781
2026
Q1
$234 Buy
+39
New +$293 ﹤0.01% 738

Other funds holding OGN

Vanguard National Trust's OGN Position: Q2 2026 in Review

Vanguard National Trust reduced its Organon & Co (OGN) stake by 74% in Q2 2026, selling an estimated $347 and leaving 10 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #781.

Vanguard National Trust first reported a position in OGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $234 in Q1 2026. 624 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Vanguard National Trust held 10 shares of Organon & Co worth $135 as of Q2 2026.
  • Vanguard National Trust sold 29 Organon & Co shares in Q2 2026, an estimated $347.
  • Organon & Co made up ﹤0.01% of Vanguard National Trust's portfolio in Q2 2026, its #781 holding.
  • Vanguard National Trust first reported a position in Organon & Co in Q1 2026 and has held it in 2 quarters since.
  • Vanguard National Trust's Organon & Co position peaked at $234 in Q1 2026.
  • 624 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.